Table 3.
Secondary outcomes
| Variable | Pre-intervention (n = 98) | Post-intervention group (n = 85) |
|---|---|---|
| Infectious complications | 38 (39%) | 38 (45%) |
| Endocarditis | 4 (4%) | 10 (12%) |
| Spondylodiscitis | 8 (8%) | 5 (6%) |
| Abscesses | 10 (10%) | 13 (15%) |
| Septic arthritis | 3 (3%) | 6 (7%) |
| Prosthetic joint infection | 5 (5%) | 7 (8%) |
| Endovascular infection | 2 (2%) | 2 (2%) |
| Relapse within 3 months | 5 (5%) | 2 (2%) |
| Cerebral septic embolism | 4 (4%) | 4 (5%) |
| Mortality | ||
| 30-day mortality | 25 (26%) | 22 (26%) |
| Uncomplicated | 3 | 1 |
| Complicated | 22 | 21 |
| Unknown/lost to FU | 2 | 1 |
| 90-day mortality | 32 (33%) | 30 (35%) |
| Uncomplicated | 4 | 3 |
| Complicated | 28 | 27 |
| Unknown/lost to FU | 3 | 1 |
Secondary outcome: complications. FU, follow-up